Owner Allergan, Inc.

Inventors Taverne, Thierry; Beausoleil, Eric; Donello, John E.; Leblond, Bertrand

Agent Davies Collison Cave

Pub. Number AU-B-2006209207

PCT Pub. Number WO2006/081280

Priority 60/647,271 26.01.05 US

Filing date 25 January 2006

Wipo publication date 3 August 2006

Acceptance publication date 23 August 2012

C07D 401/06 Heterocyclic compounds containing two or more hetero rings

A61K 31/381 - having five-membered rings

A61K 31/4409 - only substituted in position 4, e.g. isoniazid, iproniazid

A61P 29/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 37/04 Drugs for immunological or allergic disorders

C07D 211/62 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 213/56 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/64 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 413/04 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 495/04 Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms